---
title: "PTSD Epigenome-Wide Association Study in the Million Veteran Program: DNA Methylation Links to Sym"
id: "medrxiv-9-posttraumatic-stress-disorder-epigenome-wide-association-studies-in-the-million"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-9-posttraumatic-stress-disorder-epigenome-wide-association-studies-in-the-million"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.04.26362177v1?rss=1"
published_at: "2026-09-08T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# PTSD Epigenome-Wide Association Study in the Million Veteran Program: DNA Methylation Links to Sym
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-9-posttraumatic-stress-disorder-epigenome-wide-association-studies-in-the-million
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.04.26362177v1?rss=1)
- **Published At:** 2026-09-08T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The Million Veteran Program (MVP) conducted large-scale PTSD **epigenome-wide association studies (EWAS)** using DNA methylation profiles in 22,141 participants assessed with the PTSD Checklist (PCL-17). - Ancestry groups included 17,674 European (EUR), 3,430 African (AFR), and 1,037 admixed American (AMR) participants; lifetime PTSD status was derived using lasso regression on electronic health records. - Case-control totals reported were 9,413 lifetime PTSD cases and 27,257 controls across ancestries (EUR: 5,184 cases/19,382 controls; AFR: 3,095/6,240; AMR: 1,134/1,635). - The study evaluated PCL-Total and symptom subdomains (re-experiencing, avoidance, hyperarousal) and identified 241 **epigenome-wide significant CpG sites** associated with PTSD traits. - Five of 11 previously reported PTSD EWAS CpG sites from the Psychiatric Genomics Consortium were replicated in this MVP EWAS. - Cross-tissue comparison with a human postmortem brain study (amygdala and hippocampus) found overlap at the gene level: 10 genes overlapped between 195 brain-identified genes and 192 genes from the MVP EWAS. - Gene-level enrichment analysis indicated significant downregulation in **somatostatin interneurons** and **brain endothelial cells** among implicated genes. - Regression analyses associated PTSD case status with **accelerated DNA methylation aging**. - Smoking stratification suggested the previously reported association between PTSD and methylation at the **AHRR** gene may be confounded by smoking status in this dataset. - This represents the largest multi-ancestry PTSD EWAS to date and the first large EWAS assessing PTSD symptom severity; full summary statistics will be deposited to dbGaP under accession phs001672. - The study was approved by the Veterans Affairs Central Institutional Review Board and declares competing interests for some authors as reported in the source.
## Clinical Analysis & Structured Key Points
Posttraumatic Stress Disorder Epigenome-Wide Association Studies in the Million Veteran Program | medRxiv Skip to main content Posttraumatic Stress Disorder Epigenome-Wide Association Studies in the Million Veteran Program View ORCID Profile Sarah E. Beck , View ORCID Profile Daniel F. Levey , View ORCID Profile Marco Galimberti , Cassie Overstreet , View ORCID Profile Jiarui Chen , View ORCID Profile Priya Gupta , View ORCID Profile Cecilia Dao , View ORCID Profile Bluma J. Lesch , View ORCID Profile Janitza L. Montalvo-Ortiz , The V.A. Million Veteran Program , View ORCID Profile J. Michael Gaziano , View ORCID Profile John H. Krystal , View ORCID Profile Renato Polimanti , View ORCID Profile Matthew J. Girgenti , View ORCID Profile Murray B. Stein , View ORCID Profile Joel Gelernter doi: https://doi.org/10.64898/2026.09.04.26362177 Sarah E. Beck 1 Yale School of Medicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Sarah E. Beck Daniel F. Levey 2 Yale University; VA Connecticut Healthcare System; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Daniel F. Levey Marco Galimberti 3 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Marco Galimberti Cassie Overstreet 3 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Jiarui Chen 3 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Jiarui Chen Priya Gupta 4 BRIC-National Institute of Immunology; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Priya Gupta Cecilia Dao 3 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Cecilia Dao Bluma J. Lesch 3 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Bluma J. Lesch Janitza L. Montalvo-Ortiz 3 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Janitza L. Montalvo-Ortiz 5 -; J. Michael Gaziano 6 VA Boston Healthcare System; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for J. Michael Gaziano John H. Krystal 3 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for John H. Krystal Renato Polimanti 3 Yale University; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Renato Polimanti Matthew J. Girgenti 1 Yale School of Medicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Matthew J. Girgenti Murray B. Stein 7 University of California San Diego Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Murray B. Stein Joel Gelernter 1 Yale School of Medicine; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Joel Gelernter For correspondence: joel.gelernter{at}yale.edu Abstract Info/History Metrics Data/Code Preview PDF Abstract Genomic studies have improved our understanding of posttraumatic stress disorder (PTSD) biology. Epigenetic differences in DNA methylation can reflect environmental influences, which are critical in PTSD etiology, and may additionally differentiate between PTSD cases and controls or distinguish severity of PTSD symptoms. We conducted PTSD epigenome-wide association studies (EWAS) in a large cohort, n = 22,141 subjects from the United States V.A. Million Veteran Program (MVP), with the PTSD Checklist (PCL-17), including 17,674 European ancestry (EUR), 3,430 African ancestry (AFR), and 1,037 admixed American descent (AMR). We evaluated the 17-item PCL-Total as well as symptom subdomains (re-experiencing, avoidance, and hyperarousal), and used lasso regression on electronic health records to define lifetime PTSD diagnoses. There were 9,413 total cases of Lifetime PTSD and 27,257 controls, with 5,184 cases and 19,382 controls in EUR, 3,095 cases and 6,240 controls in AFR, and 1,134 cases and 1,635 controls in AMR. We identified a total of 241 epigenome-wide-significant associated CpG sites across all PTSD traits. We replicated 5 out of 11 CpG sites reported in a prior (Psychiatric Genomics Consortium) PTSD EWAS. Overlap with differentially methylated CpG sites in subregions of the amygdala and hippocampus of human postmortem brains of individuals with PTSD vs. controls was evaluated at the CpG and gene levels. Ten genes of the 195 identified in the brain study overlapped with the 192 identified in our EWAS. There was significant enrichment of genes downregulated in somatostatin interneurons and brain endothelial cells. Regression analyses showed that PTSD case status was significantly associated with accelerated DNA methylation aging. Contrary to previous PTSD EWAS findings, smoking status stratification suggested that the association between PTSD and methylation of the AHRR gene may be confounded by smoking status. Our findings showcase the largest-scale PTSD EWAS in multiple ancestries and the first large PTSD EWAS on symptom severity. We replicated several findings from previous EWAS and greatly extended current knowledge of the relationship between epigenetics and PTSD. Competing Interest Statement Dr. Gelernter is paid for editorial work for the journal Complex Psychiatry. Dr. Stein has in the past 3 years received consulting income from Abbvie, ataiBeckley, Ananda Scientific, BigHealth, Biogen, Bionomics/Neuphoria, Boehringer Ingelheim, EmpowerPharm, Engrail Therapeutics, Jazz Pharmaceuticals, Johnson and Johnson, Karuna Therapeutics, Lundbeck, Lykos Therapeutics, Newleos Therapeutics, Orion Pharma, Otsuka US, PureTech Health, Roche/Genentech, Sage Therapeutics, Seaport Therapeutics, Sensorium Therapeutics, and Transcend Therapeutics. Dr. Stein has stock options in Ananda Scientific, EpiVario, Newleos Therapeutics, and Oxeia Biopharmaceuticals. He has been paid for his editorial work on Depression and Anxiety (Editor-in-Chief), Biological Psychiatry (Deputy Editor), and UpToDate (Co-Editor-in-Chief for Psychiatry). He has also received research support from NIH, Department of Veterans Affairs, and the Department of Defense. He is on the scientific advisory board for the Brain and Behavior Research Foundation and the Anxiety and Depression Association of America. All other authors declare that they have no conflict of interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Million Veteran Program was approved by the Veterans Affairs Central Institutional Review Board. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All MVP and meta-analysis summary statistics will be made available upon publication through dbGAP, https://dbgap.ncbi.nlm.nih.gov, under accession number phs001672. Funder Information Declared United States Department of Veterans Affairs , MVP000 , I01BX006482-05 , 1IK2BX005058-01A2 National Institutes of Health, https://ror.org/01cwqze88 , 3R01DA058862 , R01DA054869 , R01DA037974 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license . Back to top Previous Next Posted September 08, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Posttraumatic Stress Disorder Epigenome-Wide Association Studies in the Million Veteran Program Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Posttraumatic Stress Disorder Epigenome-Wide Association Studies in the Million Veteran Program Sarah E. Beck , Daniel F. Levey , Marco Galimberti , Cassie Overstreet , Jiarui Chen , Priya Gupta , Cecilia Dao , Bluma J. Lesch , Janitza L. Montalvo-Ortiz , The V.A. Million Veteran Program , J. Michael Gaziano , John H. Krystal , Renato Polimanti , Matthew J. Girgenti , Murray B. Stein , Joel Gelernter medRxiv 2026.09.04.26362177; doi: https://doi.org/10.64898/2026.09.04.26362177 Share This Article: Copy Citation Tools Posttraumatic Stress Disorder Epigenome-Wide Association Studies in the Million Veteran Program Sarah E. Beck , Daniel F. Levey , Marco Galimberti , Cassie Overstreet , Jiarui Chen , Priya Gupta , Cecilia Dao , Bluma J. Lesch , Janitza L. Montalvo-Ortiz , The V.A. Million Veteran Program , J. Michael Gaziano , John H. Krystal , Renato Polimanti , Matthew J. Girgenti , Murray B. Stein , Joel Gelernter medRxiv 2026.09.04.26362177; doi: https://doi.org/10.64898/2026.09.04.26362177 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (616) Allergy and Immunology (897) Anesthesia (329) Cardiovascular Medicine (4787) Dentistry and Oral Medicine (477) Dermatology (412) Emergency Medicine (647) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1619) Epidemiology (15880) Forensic Medicine (32) Gastroenterology (1199) Genetic and Genomic Medicine (7010) Geriatric Medicine (729) Health Economics (1061) Health Informatics (5017) Health Policy (1430) Health Systems and Quality Improvement (1749) Hematology (583) HIV/AIDS (1340) Infectious Diseases (except HIV/AIDS) (16265) Intensive Care and Critical Care Medicine (1166) Medical Education (666) Medical Ethics (151) Nephrology (721) Neurology (7222) Nursing (366) Nutrition (1074) Obstetrics and Gynecology (1234) Occupational and Environmental Health (1002) Oncology (3588) Ophthalmology (1045) Orthopedics (396) Otolaryngology (449) Pain Medicine (466) Palliative Medicine (139) Pathology (705) Pediatrics (1786) Pharmacology and Therapeutics (733) Primary Care Research (760) Psychiatry and Clinical Psychology (5855) Public and Global Health (9725) Radiology and Imaging (2400) Rehabilitation Medicine and Physical Therapy (1440) Respiratory Medicine (1246) Rheumatology (637) Sexual and Reproductive Health (769) Sports Medicine (577) Surgery (774) Toxicology (107) Transplantation (303) Urology (289)
## Related Clinical Research

- [More REM (dream) sleep linked to lower risk of 83 diseases—UK Biobank study](https://medichelpline.com/clinical-feed/medical-news-today-0-more-dream-sleep-linked-to-lower-risk-of-83-diseases-including-diabetes.md)
- [Circadian Rhythm Disturbances in Young Adults: Clinical, Functional and Genetic Correlates](https://medichelpline.com/clinical-feed/medrxiv-19-cumulative-indicators-of-circadian-rhythm-disturbance-and-its-clinical.md)
- [Carbon monoxide exposure may explain lower Parkinson's risk linked to smoking](https://medichelpline.com/clinical-feed/medical-news-today-0-why-smokers-may-have-a-lower-parkinson-s-risk-it-s-not-the-nicotine.md)
- [Feasibility of SMS Screening for Mood Disturbances After Minor Stroke](https://medichelpline.com/clinical-feed/medrxiv-14-feasibility-of-sms-based-screening-for-mood-disturbances-after-minor-stroke.md)
- [Understanding Parasitic Identification in Delusional Parasitosis](https://medichelpline.com/clinical-feed/plos-one-21-bridging-perception-and-reality-parasitic-identification-in-delusional.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.